How severe is CVE-2025-36040?

CVE-2025-36040 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.

Is CVE-2025-36040 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (11th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-36040?

CVE-2025-36040 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-36040?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2025-36040 have an EU (EUVD) identifier?

Yes. CVE-2025-36040 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-23212.

When was CVE-2025-36040 published?

CVE-2025-36040 was published on 2025-07-31 and last updated on 2026-06-17.

CVE-2025-36040

CVE-2025-36040 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-613.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
EPSS exploit prediction: 0% (11th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-23212
Weakness: CWE-613
Affected product: Ibm Aspera Faspex
Published: 2025-07-31
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.0 through 5.0.12.1 could allow an authenticated user to perform unauthorized actions due to client-side enforcement of sever side security mechanisms.

Frequently asked questions

What is CVE-2025-36040?: IBM Aspera Faspex 5.0.0 through 5.0.12.1 could allow an authenticated user to perform unauthorized actions due to client-side enforcement of sever side security mechanisms.
How severe is CVE-2025-36040?: CVE-2025-36040 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2025-36040 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (11th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-36040?: CVE-2025-36040 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-36040?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-36040 have an EU (EUVD) identifier?: Yes. CVE-2025-36040 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-23212.
When was CVE-2025-36040 published?: CVE-2025-36040 was published on 2025-07-31 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7241007

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-613 (Insufficient Session Expiration) vulnerabilities

CVE-2024-8888 — Critical (CVSS 10.0): An attacker with access to the network where CIRCUTOR Q-SMT is located in its firmware version 1.0.4, could steal the…
CVE-2026-46455 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in Apache Camel Keycloak Component. The camel-keycloak security helper…
CVE-2026-21622 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in hexpm hexpm/hexpm ('Elixir.Hexpm.Accounts.PasswordReset' module)…
CVE-2025-59786 — Critical (CVSS 9.8): 2N Access Commander version 3.4.2 and prior improperly invalidates session tokens, allowing multiple session cookies to…
CVE-2026-26342 — Critical (CVSS 9.8): Tattile Smart+, Vega, and Basic device families firmware versions 1.181.5 and prior implement an authentication token…
CVE-2026-1435 — Critical (CVSS 9.8): Not properly invalidated session vulnerability in Graylog Web Interface, version 2.2.3, due to incorrect management of…

Browse all CWE-613 (Insufficient Session Expiration) vulnerabilities →